Back to ProShare Advisors LLC ProShare Advisors LLC

CPRXCPRX
31 quarters

Position history for ProShare Advisors LLCProShare Advisors LLC's holdings in CATALYST PHARMACEUTICALS INC

ProShare Advisors LLC holds 28,649 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $900,439 as of 2026-Q2. The position was increased (+59.1% shares). CPRX represents 0.0% of ProShare Advisors LLC's portfolio.

Current Value

$900,439

Current Shares

28,649

Total Value Change

+$880,439

Total Shares Change

+18,488

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
28,649
+59.1%
$900,4390.0%$31.43
36
2026-Q1
Decreased
18,010
-19.9%
$445,9270.0%$23.92
0
2025-Q4
Increased
22,499
+3.2%
$525,1270.0%$23.29
25
2025-Q3
Decreased
21,797
-15.6%
$429,4010.0%$19.55
0
2025-Q2
Decreased
25,821
-2.9%
$560,3160.0%$21.78
0
2025-Q1
Decreased
26,593
-21.1%
$644,8820.0%$24.69
0
2024-Q4
Increased
33,699
+44.5%
$703,2970.0%$21.07
33
2024-Q3
Increased
23,320
+35.9%
$463,6010.0%$19.56
31
2024-Q2
Decreased
17,162
-23.6%
$265,8400.0%$15.49
0
2024-Q1
Increased
22,457
+19.2%
$357,9650.0%$15.94
28
2023-Q4
Increased
18,843
+23.3%
$316,7510.0%$16.81
28
2023-Q3
Increased
15,279
+1.3%
$178,6110.0%$11.69
23
2023-Q2
Increased
15,087
+7.5%
$202,7690.0%$13.53
25
2023-Q1
Decreased
14,031
-8.1%
$232,6340.0%$16.46
0
2022-Q4
Increased
15,274
+15.3%
$284,0960.0%$18.60
27
2022-Q3
Increased
13,247
+23.1%
$169,0000.0%$12.70
27
2022-Q2
Decreased
10,763
-40.9%
$75,0000.0%$6.95
0
2022-Q1
Decreased
18,208
-14.2%
$151,0000.0%$8.28
0
2021-Q4
Increased
21,216
+70.5%
$143,0000.0%$6.89
33
2021-Q3
Decreased
12,442
-50.6%
$66,0000.0%$5.02
0
2021-Q2
Decreased
25,190
-2.9%
$145,0000.0%$5.78
0
2021-Q1
Increased
25,933
+20.6%
$120,0000.0%$4.34
26
2020-Q4
Increased
21,506
+80.7%
$72,0000.0%$3.42
32
2020-Q3
Decreased
11,900
-9.8%
$35,0000.0%$3.21
0
2020-Q2
New
13,191
-
$61,0000.0%$4.56
29
2020-Q1
Exited
0
-100.0%
$00.0%$3.88
0
2019-Q4
Increased
13,078
+19.0%
$49,0000.0%$3.67
24
2019-Q3
Increased
10,989
+7.6%
$58,0000.0%$5.27
22
2019-Q2
Decreased
10,214
-2.6%
$39,0000.0%$3.84
0
2019-Q1
Increased
10,487
+3.2%
$53,0000.0%$5.10
21
2018-Q4
New
10,161
-
$20,0000.0%$1.98
26

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used